Literature DB >> 23781112

'Warm-up Angina': harnessing the benefits of exercise and myocardial ischaemia.

Rupert P Williams1, Vasiliki Manou-Stathopoulou, Simon R Redwood, Michael S Marber.   

Abstract

The phenomenon of warm-up angina was first noted over 200 years ago. It describes the curious observation whereby exercise-induced ischaemia on second effort is significantly reduced or even abolished if separated from first effort by a brief rest period. However, the precise mechanism via which this cardio-protection occurs remains uncertain. Three possible explanations for reduced myocardial ischaemia on second effort include: first, an improvement in myocardial perfusion; second, increased myocardial resistance to ischaemia similar to ischaemic preconditioning; and third, reduced cardiac work through better ventricular-vascular coupling. Obtaining accurate coronary physiological measurements in the catheter laboratory throughout exercise demands a complex research protocol. In the 1980s, studies into warm-up angina relied on great cardiac vein thermo-dilution to estimate coronary blood flow. This technique has subsequently been shown to be inaccurate. However exercise physiology in the catheter laboratory has recently been resurrected with the advent of coronary artery wires that allow continuous measurement of distal coronary artery pressure and blood flow velocity. This review summarises the intriguing historical background to warm-up angina, and provides a concise critique of the important studies investigating mechanisms behind this captivating cardio-protective phenomenon.

Entities:  

Keywords:  Coronary Artery Disease; Coronary Physiology

Mesh:

Year:  2013        PMID: 23781112     DOI: 10.1136/heartjnl-2013-304187

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study.

Authors:  Aung Myat; Satpal Arri; Deepak L Bhatt; Bernard J Gersh; Simon R Redwood; Michael S Marber
Journal:  Cardiovasc Diabetol       Date:  2015-02-19       Impact factor: 9.951

Review 2.  Remote ischaemic conditioning-a new paradigm of self-protection in the brain.

Authors:  David C Hess; Rolf A Blauenfeldt; Grethe Andersen; Kristina D Hougaard; Md Nasrul Hoda; Yuchuan Ding; Xunming Ji
Journal:  Nat Rev Neurol       Date:  2015-11-20       Impact factor: 42.937

3.  Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial.

Authors:  Aung Myat; Simon R Redwood; Satpal Arri; Bernard J Gersh; Deepak L Bhatt; Michael S Marber
Journal:  Diabetol Metab Syndr       Date:  2021-02-12       Impact factor: 3.320

Review 4.  Short-term exercise-induced protection of cardiovascular function and health: why and how fast does the heart benefit from exercise?

Authors:  Dick H J Thijssen; Laween Uthman; Yasina Somani; Niels van Royen
Journal:  J Physiol       Date:  2022-03-03       Impact factor: 6.228

Review 5.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

6.  Effect of Permanent Right Internal Mammary Artery Closure on Coronary Collateral Function and Myocardial Ischemia.

Authors:  Michael Stoller; Christian Seiler
Journal:  Circ Cardiovasc Interv       Date:  2017-06       Impact factor: 6.546

7.  CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions.

Authors:  Xavier Rossello; Antonio Rodriguez-Sinovas; Gemma Vilahur; Verónica Crisóstomo; Inmaculada Jorge; Carlos Zaragoza; José L Zamorano; Javier Bermejo; Antonio Ordoñez; Lisardo Boscá; Jesús Vázquez; Lina Badimón; Francisco M Sánchez-Margallo; Francisco Fernández-Avilés; David Garcia-Dorado; Borja Ibanez
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.